Clinical trials reveal that 10-15% of participants taking GLP-1 medications like Wegovy or Mounjaro qualify as non-responders, losing less than 5% of their body weight
On the other hand, a study with a different design, namely a randomized, double-blind, placebo-controlled crossover comparison clinical trial, and partially different cohort and methodologies demonstrated that daily oral administration of very low doses (1.5 g/day) of l-ARG for a very short time (17 days) did not improve patients satisfaction with their penile erectile function and their sexual life, analyzed by the standardized KEED questionnaire for ED, in 30 middle-aged men affected by ED of mixed etiology and severity [29], suggesting that higher doses and longer-term supplementation might be required, or that l-ARG might be of particular benefit in subtypes of ED, such as those of vasculogenic etiology
The term NAFLD is used to describe a wide range of conditions, including simple steatosis (benign fat accumulation), endstage liver disease, progressive fibrosis, cirrhosis, and hepatic inflammation (steatohepatitis) (Perumpail et al., 2017
However, simply taking a glutathione supplement may not be enough
Patience is your best friend here
L.MillerK
